Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of life.
Saved in:
| Title: | Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of life. |
|---|---|
| Authors: | Wurschi GW; Department of Radiotherapy and Radiation Oncology, Jena University Hospital, Jena, Germany.; Comprehensive Cancer Center Central Germany (CCCG), Partner Site Jena, Jena, Germany., Hinz A; Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Leipzig, Germany.; Comprehensive Cancer Center Central Germany (CCCG), Partner Site Leipzig, Leipzig, Germany., Schneider M; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Becker JN; Department of Radiotherapy, Hannover Medical School, Hannover, Germany., Frerker B; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Vorbach SM; Department of Radiation Oncology, Medical University of Innsbruck, Innsbruck, Austria., Ehret F; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany., Diefenhardt M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany., Schunn F; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany., von Gruben ME; Department of Radiotherapy and Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Büttner M; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hoffmann E; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Rühle A; Comprehensive Cancer Center Central Germany (CCCG), Partner Site Leipzig, Leipzig, Germany.; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, German Cancer Consortium (DKTK), Partner Site DKTK-Freiburg, Freiburg im Breisgau, Germany.; Department of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany., Beier J; Comprehensive Cancer Center Central Germany (CCCG), Partner Site Leipzig, Leipzig, Germany.; Department of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany., Ferdinandus S; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, Köln, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Köln, Germany., Trommer M; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, Köln, Germany.; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Sahin EC; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, Essen, Germany., Hlouschek J; Department of Radiotherapy, West German Cancer Center, University Hospital Essen, Essen, Germany., Aninditha K; Department of Radiooncology, Klinikum Stuttgart, Stuttgart, Germany., von Ohlen DS; Department of Radiotherapy, University Medical Center Schleswig-Holstein/Lübeck, Lübeck, Germany., Kaufmann J; Department of Radiooncology, University Medical Center of the Johannes-Gutenberg-University Mainz, Mainz, Germany., Depardon A; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Ha HM; Department of Radiation Oncology, Otto von Guericke Universität Magdeburg, Magdeburg, Germany., Kessler C; Department of Radiation Oncology, Technical University of Munich (TUM), School of Medicine and Klinikum Rechts der Isar, München, Germany., Cieslak A; Department of Radiation Oncology, University Medicine Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Center for Radiotherapy and Radiation Oncology, Bremen, Germany., Trommer S; Department for Radiotherapy, University Hospital Halle, Halle (Saale), Germany., Fabian A; Department of Radiation Oncology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany., Rißner F; Center for Clinical Studies, Jena University Hospital, Jena, Germany., Römer M; Department of Radiotherapy and Radiation Oncology, Jena University Hospital, Jena, Germany.; Comprehensive Cancer Center Central Germany (CCCG), Partner Site Jena, Jena, Germany., Pietschmann K; Department of Radiotherapy and Radiation Oncology, Jena University Hospital, Jena, Germany.; Comprehensive Cancer Center Central Germany (CCCG), Partner Site Jena, Jena, Germany. |
| Source: | International journal of cancer [Int J Cancer] 2026 Jul 01; Vol. 159 (1), pp. 198-209. Date of Electronic Publication: 2026 Feb 18. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
